Regulation of the lifespan in dendritic cell subsets.

The lifespan of dendritic cells (DCs) can potentially influence immune responses by affecting the duration of DCs in stimulating lymphocytes. Significant differences in the lifespan have been reported for various DC subsets, however, the molecular mechanisms for regulating such differences between DC subsets remain unclear. In this study, we compared the apoptosis signaling molecules in two major DC subjects, the myeloid DCs (mDCs) and plasmacytoid DCs (pDCs). We observed a lower ratio between anti-apoptotic Bcl-2/Bcl-xL and pro-apoptotic Bax/Bak in shorter-lived myeloid DCs (mDCs) than in longer-lived plasmacytoid DCs (pDCs) or T cells. Transfection with Bcl-2 or Bcl-xL prolonged the survival of mouse primary mDCs in vitro, while deletion of Bcl-2 accelerated DC turnover in vivo. In addition, the ratios between anti-apoptotic Bcl-2/Bcl-xL and pro-apoptotic Bax/Bak could be regulated in DCs. Signaling from toll-like receptors (TLRs) up-regulated Bcl-xL and improved DC survival. Our data suggest that differential expression of apoptosis signaling molecules regulates the lifespan of different DC subsets.

[1]  J. Sprent,et al.  Lifespan of γ/δ T Cells , 1998, The Journal of experimental medicine.

[2]  R. Medzhitov,et al.  Toll-dependent selection of microbial antigens for presentation by dendritic cells , 2006, Nature.

[3]  Y. Liu,et al.  Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.

[4]  Tae Woo Kim,et al.  Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. , 2005, Cancer research.

[5]  J. Sprent,et al.  Turnover of Naive-and Memory-phenotype T Cells , 1994 .

[6]  C. Print,et al.  Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. , 1999, Cold Spring Harbor symposia on quantitative biology.

[7]  D. Tough,et al.  Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. , 2002, Blood.

[8]  S. Willis,et al.  Life in the balance: how BH3-only proteins induce apoptosis. , 2005, Current opinion in cell biology.

[9]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[10]  Tae Woo Kim,et al.  Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. , 2005, Human gene therapy.

[11]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[12]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[13]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[14]  L. Parijs,et al.  A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells , 2004, Nature Immunology.

[15]  S. Swain,et al.  IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells , 2003, The Journal of experimental medicine.

[16]  Philip G Ashton-Rickardt,et al.  Serine protease inhibitor 2A is a protective factor for memory T cell development , 2004, Nature Immunology.

[17]  V. Pascual,et al.  Autoimmunity through cytokine-induced dendritic cell activation. , 2004, Immunity.

[18]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[19]  R. Zinkernagel,et al.  Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue , 1998, The Journal of experimental medicine.

[20]  A. Strasser.  The role of BH3-only proteins in the immune system , 2005, Nature Reviews Immunology.

[21]  A. Corti,et al.  TNF-α Coupled to Membrane of Apoptotic Cells Favors the Cross-Priming to Melanoma Antigens 1 , 2004, The Journal of Immunology.

[22]  H. Sandoval,et al.  Dendritic Cell Apoptosis in the Maintenance of Immune Tolerance , 2006, Science.

[23]  L. Zheng,et al.  Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. , 1997, Journal of immunology.

[24]  Li Wu,et al.  Mouse Plasmacytoid Cells , 2002, The Journal of experimental medicine.

[25]  I. Davis,et al.  Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. , 2005, Blood.

[26]  David G. Myszka,et al.  Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex , 2001, Nature.

[27]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[28]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[29]  C. Rooney,et al.  Autoimmune disease induced by dendritic cell immunization against leukemia. , 1999, Leukemia research.

[30]  C. Thompson,et al.  Pathways of Apoptosis in Lymphocyte Development, Homeostasis, and Disease , 2002, Cell.

[31]  J. Sprent,et al.  T cell memory. , 2003, Annual review of immunology.

[32]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[33]  A. Khoruts,et al.  In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells , 1997, The Journal of experimental medicine.

[34]  A. Gambotto,et al.  Transduction of Dendritic Cells with Bcl-xL Increases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice1 , 2000, The Journal of Immunology.

[35]  M. Madaio,et al.  Fas/Fas Ligand Deficiency Results in Altered Localization of Anti-Double-Stranded DNA B Cells and Dendritic Cells1 , 2001, The Journal of Immunology.